Andre Bafica

Dr. Andre Bafica

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
HSHernandez Moura Silva
Hernandez Moura Silva
ABAndre Bafica
Andre Bafica
GRGabriela Flavia Rodrigues-Luiz
Gabriela Flavia Rodrigues-Luiz
JCJingyi Chi
Jingyi Chi
PSPatricia E. A. Santos
Patricia E. A. Santos
JLJuan J. Lafaille
Juan J. Lafaille
Tissue-resident macrophages are the most abundant immune cell population in healthy adipose tissue. Adipose tissue macrophages (ATMs) change during metabolic stress and are thought to contribute to metabolic syndrome. Here, we studied ATM subpopulations in steady state and in response to nutritional and infectious challenges. We found that tissue-resident macrophages from healthy epididymal white adipose tissue (eWAT) tightly associate with blood vessels, displaying very high endocytic capacity. We refer to these cells as vasculature-associated ATMs (VAMs). Chronic high-fat diet (HFD) results in the accumulation of a monocyte-derived CD11c+CD64+ double-positive (DP) macrophage eWAT population with a predominant anti-inflammatory/detoxifying gene profile, but reduced endocytic function. In contrast, fasting rapidly and reversibly leads to VAM depletion, while acute inflammatory stress induced by pathogens transiently depletes VAMs and simultaneously boosts DP macrophage accumulation. Our results indicate that ATM populations dynamically adapt to metabolic stress and inflammation, suggesting an important role for these cells in maintaining tissue homeostasis.

9 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ÁMÁlvaro Menin
Álvaro Menin
RFRenata Fleith
Renata Fleith
CRCarolina Reck
Carolina Reck
MMMariel Marlow
Mariel Marlow
PFPaula Fernandes
Paula Fernandes
ABAndre Bafica
Andre Bafica
Rational discovery of novel immunodiagnostic and vaccine candidate antigens to control bovine tuberculosis (bTB) requires knowledge of disease immunopathogenesis. However, there remains a paucity of information on the Mycobacterium bovis-host immune interactions during the natural infection. Analysis of 247 naturally PPD+ M. bovis-infected cattle revealed that 92% (n = 228) of these animals were found to display no clinical signs, but presented severe as well as disseminated bTB-lesions at post-mortem examination. Moreover, dissemination of bTB-lesions positively correlated with both pathology severity score (Spearman r = 0.48; p<0.0001) and viable tissue bacterial loads (Spearman r = 0.58; p = 0.0001). Additionally, granuloma encapsulation negatively correlated with M. bovis growth as well as pathology severity, suggesting that encapsulation is an effective mechanism to control bacterial proliferation during natural infection. Moreover, multinucleated giant cell numbers were found to negatively correlate with bacterial counts (Spearman r = 0.25; p = 0.03) in lung granulomas. In contrast, neutrophil numbers in the granuloma were associated with increased M. bovis proliferation (Spearman r = 0.27; p = 0.021). Together, our findings suggest that encapsulation and multinucleated giant cells control M. bovis viability, whereas neutrophils may serve as a cellular biomarker of bacterial proliferation during natural infection. These data integrate host granuloma responses with mycobacterial dissemination and could provide useful immunopathological-based biomarkers of disease severity in natural infection with M. bovis, an important cattle pathogen.

15 February 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PSPaula Fernandes dos Santos
Paula Fernandes dos Santos
JWJohan Van Weyenbergh
Johan Van Weyenbergh
MDMurilo Delgobo
Murilo Delgobo
DPDaniel de Oliveira Patricio
Daniel de Oliveira Patricio
BFBrian Ferguson
Brian Ferguson
DMDaniel Mansur
Daniel Mansur
IFN-stimulated gene 15 (ISG15) deficiency in humans leads to severe IFNopathies and mycobacterial disease, the latter being previously attributed to its extracellular cytokine-like activity. In this study, we demonstrate a novel role for secreted ISG15 as an IL-10 inducer, unique to primary human monocytes. A balanced ISG15-induced monocyte/IL-10 versus lymphoid/IFN-γ expression, correlating with p38 MAPK and PI3K signaling, was found using targeted in vitro and ex vivo systems analysis of human transcriptomic datasets. The specificity and MAPK/PI3K-dependence of ISG15-induced monocyte IL-10 production was confirmed in vitro using CRISPR/Cas9 knockout and pharmacological inhibitors. Moreover, this ISG15/IL-10 axis was amplified in leprosy but disrupted in human active tuberculosis (TB) patients. Importantly, ISG15 strongly correlated with inflammation and disease severity during active TB, suggesting its potential use as a biomarker, awaiting clinical validation. In conclusion, this study identifies a novel anti-inflammatory ISG15/IL-10 myeloid axis that is disrupted in active TB.

1 May 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
TFTatiany J. de Faria
Tatiany J. de Faria
MRMariane Roman
Mariane Roman
NSNicole M. de Souza
Nicole M. de Souza
RVRodrigo De Vecchi
Rodrigo De Vecchi
JAJoão Vitor de Assis
João Vitor de Assis
ABAndre Bafica
Andre Bafica
Nanoenabled drug delivery systems against tuberculosis (TB) are thought to control pathogen replication by targeting antibiotics to infected tissues and phagocytes. However, whether nanoparticle (NP)-based carriers directly interact with Mycobacterium tuberculosis and how such drug delivery systems induce intracellular bacterial killing by macrophages is not defined. In the present study, we demonstrated that a highly hydrophobic citral-derived isoniazid analogue, termed JVA, significantly increases nanoencapsulation and inhibits M. tuberculosis growth by enhancing intracellular drug bioavailability. Importantly, confocal and atomic force microscopy analyses revealed that JVA-NPs associate with both intracellular M. tuberculosis and cell-free bacteria, indicating that NPs directly interact with the bacterium. Taken together, these data reveal a nanotechnology-based strategy that promotes antibiotic targeting into replicating extra- and intracellular mycobacteria, which could actively enhance chemotherapy during active TB.

22 October 2019 in eLife
Verified
Journal Article
Open access
MDMurilo Delgobo
Murilo Delgobo
DMDaniel Agb Mendes
Daniel Agb Mendes
EKEdgar Kozlova
Edgar Kozlova
EREdroaldo Lummertz Rocha
Edroaldo Lummertz Rocha
GRGabriela F Rodrigues-Luiz
Gabriela F Rodrigues-Luiz
ABAndre Bafica
Andre Bafica
Monocyte counts are increased during human tuberculosis (TB) but it has not been determined whether Mycobacterium tuberculosis (Mtb) directly regulates myeloid commitment. We demonstrated that exposure to Mtb directs primary human CD34+ cells to differentiate into monocytes/macrophages. In vitro myeloid conversion did not require type I or type II IFN signaling. In contrast, Mtb enhanced IL-6 responses by CD34+ cell cultures and IL-6R neutralization inhibited myeloid differentiation and decreased mycobacterial growth in vitro. Integrated systems biology analysis of transcriptomic, proteomic and genomic data of large data sets of healthy controls and TB patients established the existence of a myeloid IL-6/IL6R/CEBP gene module associated with disease severity. Furthermore, genetic and functional analysis revealed the IL6/IL6R/CEBP gene module has undergone recent evolutionary selection, including Neanderthal introgression and human pathogen adaptation, connected to systemic monocyte counts. These results suggest Mtb co-opts an evolutionary recent IFN-IL6-CEBP feed-forward loop, increasing myeloid differentiation linked to severe TB in humans.

1 December 2014 in Microbes and Infection
Verified
Journal Article
Closed access
LYLívia Harumi Yamashiro
Lívia Harumi Yamashiro
SOSérgio Costa Oliveira
Sérgio Costa Oliveira
ABAndre Bafica
Andre Bafica